Phase II Trial of Combination Intraperitoneal Cisplatin and 5-Fluorouracil in Previously Treated Patients with Advanced Ovarian Cancer: Long-Term Follow-up
- 30 June 2000
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 77 (3) , 433-438
- https://doi.org/10.1006/gyno.2000.5793
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Intraperitoneal ChemotherapyPublished by Elsevier ,2003
- The Role of Chemotherapy in the Management of Celomic Epithelial Carcinoma of the OvaryCancer Investigation, 1997
- Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian CancerNew England Journal of Medicine, 1996
- Intraperitoneal Mitoxantrone or Floxuridine: Effects on Time-to-Failure and Survival in Patients with Minimal Residual Ovarian Cancer after Second-Look Laparotomy—A Randomized Phase II Study by the Southwest Oncology GroupGynecologic Oncology, 1996
- Intraperitoneal Administration of Cisplatin and 5-Fluorouracil in Residual Ovarian Cancer: A Phase II Gynecologic Oncology Group TrialGynecologic Oncology, 1995
- Cancer of the OvaryNew England Journal of Medicine, 1993
- Intraperitoneal chemotherapy in the management of ovarian cancerCancer, 1993
- Second‐line chemotherapy for recurrent carcinoma of the ovaryCancer, 1993
- Dose: A critical factor in cancer chemotherapyThe American Journal of Medicine, 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958